Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000950170-25-034626
Filing Date
2025-03-06
Accepted
2025-03-06 16:10:08
Documents
11
Period of Report
2025-01-07
Items
Item 2.05: Cost Associated with Exit or Disposal Activities

Document Format Files

Seq Description Document Type Size
1 8-K/A igms-20250107.htm   iXBRL 8-K/A 48851
  Complete submission text file 0000950170-25-034626.txt   176438

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT igms-20250107.xsd EX-101.SCH 32364
13 EXTRACTED XBRL INSTANCE DOCUMENT igms-20250107_htm.xml XML 5643
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

EIN.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39045 | Film No.: 25715289
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)